MENU

Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

ENTA is expected to report earnings to fall 3.40% to -141 cents per share on August 06

Enanta Pharmaceuticals ENTA Stock Earnings Reports
Q2'24
Est.
$-1.42
Q1'24
Missed
by $0.13
Q4'23
Missed
by $1.75
Q3'23
Beat
by $0.79
Q2'23
Beat
by $0.39
The last earnings report on May 06 showed earnings per share of -147 cents, missing the estimate of -134 cents. With 100.00 shares outstanding, the current market capitalization sits at 317.27M.
View a ticker or compare two or three
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com